Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.91−0.13 (-12.46%)
Close on Nov 13, 2026Market cap $47.03MP/E –Yield –
Talphera ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Talphera's ebitda for the twelve months ending Dec 31, 2024 was -$15.25M. For fiscal 2024 it was -$15.25M. The highest annual figure on record is -$6.07M in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$15.25M | – |
| FY2023 | Dec 31, 2023 | -$16.58M | – |
| FY2022 | Dec 31, 2022 | -$23.65M | – |
| FY2021 | Dec 31, 2021 | -$33.99M | – |
| FY2020 | Dec 31, 2020 | -$39.11M | – |
| FY2019 | Dec 31, 2019 | -$52.54M | – |
| FY2018 | Dec 31, 2018 | -$35.15M | – |
| FY2017 | Dec 31, 2017 | -$36.94M | – |
| FY2016 | Dec 31, 2016 | -$29.91M | – |
| FY2015 | Dec 31, 2015 | -$17.97M | – |
| FY2014 | Dec 31, 2014 | -$36.78M | – |
| FY2013 | Dec 31, 2013 | -$6.07M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$3.00M | -170.6% |
| Q3 FY2024 | Sep 30, 2024 | -$3.75M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.27M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.07M | – |
| Q4 FY2022 | Dec 31, 2022 | $4.24M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.21M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.11M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.52M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.15M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.44M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.86M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.48M | – |
| Q3 FY2019 | Sep 30, 2019 | -$13.12M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.96M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.99M | – |
| Q4 FY2018 | Dec 31, 2018 | -$10.84M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.19M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.01M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.12M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.45M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.47M | – |
| Q1 FY2017 | Mar 31, 2017 | -$11.59M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.63M | – |
See a number that looks wrong?